IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,235,056 | +15.2% | 159,503 | +4.2% | 1.33% | +21.8% |
| Q2 2023 | $6,279,724 | +16.2% | 153,052 | +1.3% | 1.09% | -7.3% |
| Q1 2023 | $5,402,494 | +1.4% | 151,161 | +7.1% | 1.18% | -17.2% |
| Q4 2022 | $5,329,914 | -50.2% | 141,115 | -41.7% | 1.42% | -53.4% |
| Q3 2022 | $10,701,000 | +65.8% | 241,945 | +38.8% | 3.04% | +28.0% |
| Q2 2022 | $6,453,000 | +164.3% | 174,300 | +117.2% | 2.38% | +340.8% |
| Q4 2021 | $2,442,000 | -46.6% | 80,238 | -41.2% | 0.54% | -53.4% |
| Q3 2021 | $4,574,000 | -15.9% | 136,380 | 0.0% | 1.16% | -2.7% |
| Q2 2021 | $5,440,000 | +14.4% | 136,380 | +28.9% | 1.19% | +7.7% |
| Q1 2021 | $4,757,000 | +11.6% | 105,797 | +40.3% | 1.10% | +1.1% |
| Q4 2020 | $4,264,000 | – | 75,418 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |